Thomas, McNerney & Partners

Thomas, McNerney & Partners is a healthcare venture capital firm specializing in life science and medical technology investments across all stages of development. The firm focuses on sectors such as biotechnology, pharmaceuticals, medical devices, and diagnostics, providing funding to companies at various stages, from seed and early-stage funding to growth capital for emerging companies. They also assist in spinning out products and divisions from major medical device and pharmaceutical companies, consolidating companies through roll-up strategies, and participating in structured financings and recapitalizations. The firm has offices in Connecticut, Minnesota, and California.

Established in 2001 by James E. Thomas and Peter H. McNerney, the firm has approximately $600 million under management. Their investment strategy includes leading investments in biotechnology, pharmaceutical, and medical device companies across all stages of development. The firm has a history of investing in companies developing therapeutic products for life-threatening or costly, chronic conditions. They have been involved in various investments, including those in the pharmaceutical, medical device, biotechnology, and diagnostic sectors, as well as other areas utilizing medical technology innovation.

The firm's team comprises professionals with extensive experience in healthcare operations and venture capital. Co-founders James E. Thomas and Peter H. McNerney previously led healthcare investments at Coral Ventures and Warburg Pincus. The firm has been active in promoting members within its investment team, reflecting its commitment to internal growth and development. For instance, in January 2011, Kathy Tune was promoted to Partner, and Anya Schiess to Vice President, acknowledging their significant contributions to the firm.